A new contract for integrated care
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explain how the new GP contract will shape local joined-up systems
Search Results for: Paul Midgley and Oli Hudson
How can pharma support NHS transformation?
Steve How, Paul Midgley and Oli Hudson of the Wilmington Consulting Team find some answers in recently updated NHS England guidance
Read More
Care in the home
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how patients are increasingly being empowered to manage their conditions at home
Read More
After shock?
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore the impact of the Tories’ historic win on the NHS and pharma in 2020 and beyond
Read More
2019 – a momentous year for the NHS
Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore how the Long Term Plan has been driving transformation in the NHS this year
- Nova’s Xromi approved in UK and EU for vaso-occlusive complications of SCD
- Study reveals vitamin D-altered mouse gut bacteria provides better cancer immunity
- Cambridge researchers use AI to accelerate drug design for Parkinson’s disease
- Study finds mechanical changes in tumour tissue offer new insights for cancer research
- Cambridge study finds AI more accurately assesses eye problems compared to doctors
